← Leaderboards
Thomas Westbrook
Baylor College Of Medicine
$11,281,446
Attributed
$11,281,446
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,281,446 · 7
By mechanism
R01$7,711,549 · 3
P30$1,955,390 · 3
P50$1,614,507 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Huda Y Zoghbi$38,140,328
- Puneet Opal$12,814,603
- James P Orengo$2,603,782
- Juan Botas$8,658,926
- Eric David Hyun$73,580
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsGeneticMalignant NeoplasmsGenomeGenesCellsBaseIn VivoSignal TransductionOncogenicMolecularGenomicsGenetic ScreeningTechnologyResponseNeoplastic CellGenetic TranscriptionRna InterferenceMemberTumorCombatMalignant Breast NeoplasmTriple-Negative Invasive Breast CarcinomaStructure
Grant awards (39)
Therapeutic Targeting of RNA Splicing in Triple-Negative Breast Cancer$714,768
R01 · FY2025 · CA · contact PI
Therapeutic Targeting of RNA Splicing in Triple-Negative Breast Cancer$680,534
R01 · FY2024 · CA · contact PI
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer$271,773
P50 · FY2024 · CA · contact PI
Therapeutic Targeting of RNA Splicing in Triple-Negative Breast Cancer$717,288
R01 · FY2023 · CA · contact PI
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer$331,761
P50 · FY2023 · CA · contact PI
New Vulnerabilities in MYC-Driven Breast Cancer$538,015
R01 · FY2022 · CA · contact PI
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer$337,055
P50 · FY2022 · CA · contact PI
New Vulnerabilities in MYC-Driven Breast Cancer$548,922
R01 · FY2021 · CA · contact PI
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors$362,569
R01 · FY2021 · CA · contact PI
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer$335,225
P50 · FY2021 · CA · contact PI
New Vulnerabilities in MYC-Driven Breast Cancer$588,388
R01 · FY2020 · CA · contact PI
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors$382,301
R01 · FY2020 · CA · contact PI
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer$338,693
P50 · FY2020 · CA · contact PI
New Vulnerabilities in MYC-Driven Breast Cancer$551,250
R01 · FY2019 · CA · contact PI
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors$351,691
R01 · FY2019 · CA · contact PI
Shared Resource: Cell-Based Assay Screening Service$126,321
P30 · FY2019 · CA · contact PI
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors$63,566
R01 · FY2019 · CA · contact PI
New Vulnerabilities in MYC-Driven Breast Cancer$598,309
R01 · FY2018 · CA · contact PI
Shared Resource: Cell-Based Assay Screening Service$117,626
P30 · FY2018 · CA · contact PI
Shared Resource: Cell-Based Assay Screening Service$10,000
P30 · FY2018 · CA · contact PI
Shared Resource: Cell-Based Assay Screening Service$4,755
P30 · FY2018 · CA · contact PI
Discovering genetic networks of triple-negative breast cancer$324,738
R01 · FY2017 · CA · contact PI
Shared Resource: Cell-Based Assay Screening Service$101,820
P30 · FY2017 · CA · contact PI
Discovering genetic networks of triple-negative breast cancer$324,738
R01 · FY2016 · CA · contact PI
Shared Resource: Cell-Based Assay Screening Service$101,820
P30 · FY2016 · CA · contact PI
Discovering genetic networks of triple-negative breast cancer$324,738
R01 · FY2015 · CA · contact PI
Shared Resource: Cell-Based Assay Screening Service$127,054
P30 · FY2015 · CA · contact PI
Discovering genetic networks of triple-negative breast cancer$314,996
R01 · FY2014 · CA · contact PI
GENOME WIDE RNAI SCREENING AND ANALYSIS$75,493
P30 · FY2014 · CA · contact PI
Discovering genetic networks of triple-negative breast cancer$324,738
R01 · FY2013 · CA · contact PI
GENOME WIDE RNAI SCREENING AND ANALYSIS$133,268
P30 · FY2013 · CA · contact PI
CORE C: Genome Wide RNAi Screens$96,023
P30 · FY2013 · HD · contact PI
CORE C: Genome Wide RNAi Screens$202,634
P30 · FY2012 · HD · contact PI
GENOME WIDE RNAI SCREENING AND ANALYSIS$81,394
P30 · FY2012 · CA · contact PI
CORE C: Genome Wide RNAi Screens$201,902
P30 · FY2011 · HD · contact PI
GENOME WIDE RNAI SCREENING AND ANALYSIS$83,413
P30 · FY2011 · CA · contact PI
CORE C: Genome Wide RNAi Screens$201,639
P30 · FY2010 · HD · contact PI
GENOME WIDE RNAI SCREENING AND ANALYSIS$92,092
P30 · FY2010 · CA · contact PI
CORE C: Genome Wide RNAi Screens$198,136
P30 · FY2009 · HD · contact PI